IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-01-31 (pharmabiz.net)
Passes: last January newsletter -
Germán de la Key is the new medical director of Personal Union - Accord Salud. After being the director of access and government matters of the British AZ until the end of 2021 this graduate doctor of the University of Salvador returns to the sector of service providers. Prior to Az […]
Read more
2024-11-06 (businesswire.com)
IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024 | Business Wire
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the U
Read more
2024-11-05 (cxodigitalpulse.com)
Karthik SM Joins Biocon Biologics as Vice President of Human Resources
Karthik SM has been appointed as the Vice President of Human Resources at Biocon Biologics, leveraging his extensive experience in ...
Read more
2024-10-30 (investing.com)
GoodRx Appoints IQVIA CFO to Its Board of Directors for Financial Expertise By Investing.com
GoodRx Appoints IQVIA CFO to Board of Directors for Financial Expertise
Read more
2024-10-30 (investing.com)
GoodRx seeks financial expertise, appoints IQVIA CFO to board of directors Written by: Investing.com
SANTA MONICA, Calif. - GoodRx Holdings, Inc. (NASDAQ: GDRX), the leading U.S. prescription savings platform, today announced its 2024... On November 8, we announced the appointment of Mr. Ronald E. Bruehlman to our Board of Directors. Mr. Bruehlman, who currently serves as IQVIA's chief financial officer (CFO), brings nearly 40 years of financial experience in the healthcare field.
Read more
2024-10-16 (green-reporter.com)
Can Passion and Profit Coexist in Pharma ESG Efforts?
Pharmaceutical Executive convened an executive roundtable discussion during The Vanguard Network’s Life Sciences CEO Forum on May 21, 2024, in
Read more
2024-09-22 (hrtoday.in)
Blanka Demeter Appointed as Director, Talent Acquisition at IQVIA
Barcelona, Spain, September 2024 – Blanka Demeter has been appointed as the Director, Talent Acquisition at IQVIA, a global leader
Read more
2024-09-19 (pharmaboardroom.com)
Jorge Luis Caridad – Managing Director, Johnson & Johnson Innovative Medicine, Mexico
Jorge Luis Caridad, managing director of Johnson & Johnson Innovative Medicine, Mexico, explores…
Read more
2024-09-03 (rozanaspokesman.com)
Who is Jasdeep Singh Gill, the new head of Radha Soami Dera Beas? Know all about him
Who is Jasdeep Singh Gill, the new head of Radha Soami Dera Beas? Jasdeep Singh Gill, recently appointed as the head of Radha Soami Dera Beas, brings a wealth of experience from his extensive career in the healthcare and pharmaceutical industries.
Read more
2024-08-01 (pharmaphorum.com)
Changing Faces – Pharma and biotech May and June 2024
Stay updated on the latest hiring news and developments from Pfizer, Lilly, Gilead, Epsilogen, and other pharma and biotech companies in May and June 2024 with Changing Faces.
Read more
2024-01-22 (wiadomoscikosmetyczne.pl)
Anna Pielak from Empik to DOZ
Anna Pielak moved from the Empik Group to DOZ, where she took up the position of director of the dermo and OTC products division.
Read more
2023-11-21 (yahoo.com)
IQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx Conference on November 29, 2023
INNOVATION PARK, N.C., November 21, 2023--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Evercore Annual HealthCONx Conference in Miami on Wednesday, November 29, 2023 at 10:50 a.m. ET.
Read more
Used by 100+ compliance teams and analysts